Short-course intranasal LAT9997 therapy limits post-influenza bacterial pneumonia by recalibrating...
Influenza A virus (IAV) infection remains a major global health threat, not only due to its direct impact but also its role in predisposing the respiratory tract to secondary bacterial infections.1...
mucosalimmunology.org